Vascular Solutions Top Management
Vascular Solutions employs about 568 people. The company is managed by 17 executives with a total tenure of roughly 253 years, averaging almost 14.0 years of service per executive, having 33.41 employees per reported executive. Evaluation of Vascular Solutions' management performance can provide insight into the firm performance.
Howard Root CEO Co-Founder, CEO and Director |
John Erb Chairman Independent Chairman of the Board |
Vascular |
Vascular Solutions Management Team Effectiveness
The company has return on total asset (ROA) of 0.13 % which means that it generated a profit of $0.13 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.15 %, meaning that it created $0.15 on every $100 dollars invested by stockholders. Vascular Solutions' management efficiency ratios could be used to measure how well Vascular Solutions manages its routine affairs as well as how well it operates its assets and liabilities.The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 9.41 %, which suggests for every 100 dollars of sales, it generated a net operating income of $9.41.
Vascular Solutions Notable Stakeholders
A Vascular Solutions stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vascular Solutions often face trade-offs trying to please all of them. Vascular Solutions' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vascular Solutions' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Howard Root | Co-Founder, CEO and Director | Profile | |
John Erb | Independent Chairman of the Board | Profile | |
Brett Demchuk | Vice President - Product Quality | Profile | |
Phillip Nalbone | Vice President - Corporate Development | Profile | |
Jonathan Hammond | Vice President - Manufacturing Engineering | Profile | |
Susan Christian | Vice President - Sales Operations | Profile | |
James Hennen | CFO and Sr. VP of Fin. | Profile | |
Brent Binkowski | Sr. VP of Operations | Profile | |
William Rutstein | Sr. VP of International Sales | Profile | |
Charmaine Sutton | Sr. VP of Operations | Profile | |
Chad Kugler | Sr. VP of RandD | Profile | |
Richard Kramp | Independent Director | Profile | |
Jorge Saucedo | Independent Director | Profile | |
Martin Emerson | Independent Director | Profile | |
Richard Nigon | Independent Director | Profile | |
Paul OConnell | Independent Director | Profile | |
Carrie Powers | VP of Marketing | Profile |
Vascular Solutions Workforce Analysis
Traditionally, organizations such as Vascular Solutions use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vascular Solutions within its industry.Vascular Solutions Manpower Efficiency
Return on Vascular Solutions Manpower
Revenue Per Employee | 281.7K | |
Revenue Per Executive | 9.4M | |
Net Income Per Employee | 21.4K | |
Net Income Per Executive | 714.1K | |
Working Capital Per Employee | 133.4K | |
Working Capital Per Executive | 4.5M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Solutions' history and understand the potential risks before investing.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |